Ming capital
Venture capitalShenzhen · Seed–Late Stage · 6 people tracked
Investment thesis
Ming Capital is a global healthcare-focused venture capital firm dedicated to improving human health by supporting medical breakthroughs, particularly in innovative medicine, medical devices, and in-vitro diagnostics (IVD). Through onshore-offshore parallel funds and parallel investments, the firm seeks to combine worldwide resources across medical innovation, entrepreneurship, management, and commercial and capital markets. Its strategic goals center on supporting entrepreneurs, delivering returns to investors, rewarding partners, and enhancing health, guided by values of collective wisdom and integrity for value creation.
Source: firm website, verified Aug 7, 2026.
Team · 6 people
from the firm's website & public directoriesWhat they invest in
from 6 of 18 portfolio companiesDeep Tech ×2Hardware ×2Healthtech ×2Media & Entertainment ×2Medical Devices ×2Biotech ×1Fintech ×1Robotics ×1
HQs:China×4
Investments · 18 tracked
founders shown can be your intro pathGuangzhou-based developer of small molecule drugs for lymphoma, lung cancer, and ovarian cancer, including BEBT-908, a dual-target drug for recurrent or refractory lymphoma.
Wuhan-area developer of oncolytic virus immunotherapy in China.
QQ.com is a Chinese web portal and content platform operated by Tencent that aggregates news, entertainment, gaming, and other digital services.
Media & EntertainmentShenzhen, CN
Charlottesville, Virginia MedTech company commercializing wearable monitoring devices based on patented Pulse Decomposition Analysis technology.
Exit; company using proprietary deep packet inspection (DPI) technology to help Chinese local internet network owners monitor and monetize network access points.
Edadoc (Yibo) is a Chinese electronics engineering services company focused on PCB design, high-speed circuit layout, and related hardware development support.
Deep TechHardwareRoboticsShenzhen, CN
Shenzhen-based one-stop hardware innovation platform for high-speed PCB design, prototyping, and batch PCBA production; listed on the Shenzhen Growth Enterprise Market (301366).
Shenzhen company developing packaging and producer cell lines for lenti-virus and AAV production, plus automated biotech R&D equipment.
Chengdu-based developer of AAV-based gene therapies for conditions such as AMD and XLRS.
Gordian Surgical develops the TroClose, an FDA-cleared integrated trocar and wound closure device that combines laparoscopic port access with automated port-site closure.
HardwareMedical Devices
Netanya, Israel medical robotics company developing software-driven handheld surgical devices.
Exit; medical device company developing cerebral embolic protection (CEP) devices to reduce stroke risk.
Miracor develops PiCSO (Pressure-controlled intermittent Coronary Sinus Occlusion), a therapy used during percutaneous coronary intervention (PCI) to treat acute myocardial infarction patients.
HealthtechMedical Devices
Exit; technology company providing automatic identification products, IoT mobile products, and enterprise mobile application services.
Ophthalmic technology company founded in Silicon Valley in 2014, now operating across Silicon Valley, Shanghai, and Luoyang.
PEdaily (投资界) is a Chinese online media platform published by Zero2IPO Group that reports on venture capital, private equity, startup fundraising, IPOs, and M&A.
FintechMedia & Entertainment
Frequently asked questions
- What stage does Ming capital invest at?
- Ming capital invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does Ming capital focus on?
- Ming capital focuses on Biotech, Digital Health, Healthtech, Medical Devices, Robotics.
- Where is Ming capital located?
- Ming capital is headquartered in Shenzhen, CN.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.